MedTrace Logo

A Comparative Study of Mefloquine and S-P as Prophylaxis Against Malaria in Pregnant HIV + Patients

NCT02524444 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 142

Last updated 2017-12-11

No results posted yet for this study

Summary

Randomized controlled single blind prospective comparative study.

Conditions

  • Malaria in Pregnant HIV + Patients

Interventions

DRUG

Mefloquine

Tabs Mefloquine 250mg

DRUG

Sulphadoxine-Pyrimethamine

Sulphadoxine 500mg , Pyrimethamine 25mg

Sponsors & Collaborators

  • University of Ibadan

    collaborator OTHER

  • ORIYOMI OMOTOYOSI AKINYOTU

    lead OTHER

Principal Investigators

  • AYODELE O AROWOJOLU, MBBS IBADAN · UNIVERSITY COLLEGE HOSPITAL,IBADAN,OYO STATE, NIGERIA

  • ORIYOMI O AKINYOTU, MBBS IBADAN · UNIVERSITY COLLEGE HOSPITAL,IBADAN,OYO STATE,NIGERIA

  • ADENIKE F BELLO, MBBS IBADAN · UNIVERSITY COLLEGE HOSPITAL,IBADAN,OYO STATE, NIGERIA

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • Nigeria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02524444 on ClinicalTrials.gov